GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,017,000 | -80.8% | 132,397 | -91.0% | 0.00% | -81.8% |
| Q2 2022 | $46,920,000 | -35.2% | 1,468,554 | -29.7% | 0.01% | -26.7% |
| Q1 2022 | $72,384,000 | +33.4% | 2,089,632 | +12.8% | 0.02% | +36.4% |
| Q4 2021 | $54,242,000 | +1026.1% | 1,853,156 | +880.4% | 0.01% | – |
| Q3 2021 | $4,817,000 | -18.5% | 189,029 | +12.0% | 0.00% | -100.0% |
| Q2 2021 | $5,911,000 | -88.5% | 168,800 | -86.7% | 0.00% | -92.3% |
| Q1 2021 | $51,559,000 | +96.1% | 1,265,253 | +108.4% | 0.01% | +85.7% |
| Q4 2020 | $26,292,000 | -42.3% | 607,045 | -26.5% | 0.01% | -46.2% |
| Q3 2020 | $45,550,000 | +56.6% | 826,072 | +79.3% | 0.01% | +18.2% |
| Q2 2020 | $29,088,000 | +70.7% | 460,765 | +38.1% | 0.01% | +57.1% |
| Q1 2020 | $17,044,000 | -74.3% | 333,594 | -60.0% | 0.01% | -75.9% |
| Q4 2019 | $66,282,000 | +323.2% | 833,850 | +158.3% | 0.03% | +314.3% |
| Q3 2019 | $15,663,000 | -51.9% | 322,809 | -47.9% | 0.01% | -50.0% |
| Q2 2019 | $32,570,000 | +77.2% | 619,207 | +78.3% | 0.01% | +55.6% |
| Q1 2019 | $18,382,000 | +136.8% | 347,305 | +83.6% | 0.01% | +80.0% |
| Q4 2018 | $7,763,000 | +0.5% | 189,122 | -7.0% | 0.01% | +66.7% |
| Q3 2018 | $7,723,000 | -51.7% | 203,251 | -42.6% | 0.00% | -62.5% |
| Q2 2018 | $15,993,000 | +99.2% | 353,832 | +112.9% | 0.01% | +100.0% |
| Q1 2018 | $8,029,000 | -71.5% | 166,210 | -76.8% | 0.00% | -76.5% |
| Q4 2017 | $28,199,000 | +231.7% | 716,611 | +161.7% | 0.02% | +183.3% |
| Q3 2017 | $8,501,000 | -79.4% | 273,783 | -81.9% | 0.01% | -82.4% |
| Q2 2017 | $41,308,000 | +24.0% | 1,510,335 | +67.1% | 0.03% | +13.3% |
| Q1 2017 | $33,309,000 | +4805.6% | 903,952 | +1825.9% | 0.03% | – |
| Q4 2016 | $679,000 | -47.4% | 46,936 | -16.2% | 0.00% | -100.0% |
| Q3 2016 | $1,291,000 | – | 56,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |